Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19
Ιoannis Ilias, Spyridon Goulas, Lina Zabulienė
Abstract
locally-expressed angiotensin converting enzyme type 2 receptors. Excess body weight is associated with more severe COVID-19 and increased mortality. Although robust links between SARS-CoV-2 infection and PCOS/NAFLD/gut microbiome/metabolic consequences are yet to be confirmed, it seems that strategies for adapting the intestinal microbiome could help reduce the severity of COVID-19 in women with PCOS with or without NAFLD, MetSy or obesity.
Topics & Concepts
MedicinePolycystic ovaryCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)OvaryInternal medicineGynecologyVirologyInsulin resistanceObesityDiseaseOutbreakInfectious disease (medical specialty)Ovarian function and disordersCOVID-19 Impact on ReproductionOvarian cancer diagnosis and treatment